会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 17. 发明授权
    • System for card to card transfer of monetary values
    • 卡转卡系统的货币价值
    • US06394343B1
    • 2002-05-28
    • US09418059
    • 1999-10-14
    • Jon N. BergEric L. Nelson
    • Jon N. BergEric L. Nelson
    • G06F1760
    • G07F7/1008G06K7/0008G06K7/0021G06K19/04G06K19/0728G06K19/077G06K19/07703G06K19/07749G06Q20/3415
    • A smart card stores monetary values and selectively transfers monetary values to and receives monetary values from a compatible smart card. The smart card includes a data storage device that stores data representing monetary values. Control circuitry controls the transfer of the monetary values into the data storage device and controls the transfer of the monetary values out of the data storage device. A data transfer interface couples directly to a like interface on the compatible card to enable data to be transferred between the smart card and the compatible card. A system for electronic transfer of monetary values includes first and second smart cards. Each of the first and second smart cards includes a data storage device that stores data representing monetary values.
    • 智能卡存储货币价值,并选择性地将货币价值转移到兼容智能卡并从其获取货币价值。 智能卡包括存储表示货币值的数据的数据存储装置。 控制电路控制货币值转移到数据存储装置中并控制货币值从数据存储装置传出。 数据传输接口直接耦合到兼容卡上的类似接口,以使数据能够在智能卡和兼容卡之间传输。 电子货币转移系统包括第一和第二智能卡。 第一和第二智能卡中的每一个包括存储表示货币值的数据的数据存储装置。
    • 19. 发明授权
    • Inhibition of platelet aggregation with selected phosphonic and
phosphinic acid esters
    • 用选择的膦酸和次膦酸酯抑制血小板聚集
    • US4148879A
    • 1979-04-10
    • US864017
    • 1977-12-23
    • Eric L. Nelson
    • Eric L. Nelson
    • A61K31/66A61K35/14A61K31/685
    • A61K31/685A61K31/66
    • A process for inhibiting platelet aggregation or thrombus formation by the addition of a member selected from the group consisting of a compound of the formula: ##STR1## WHEREIN X is an alkyl or alkenyl chain having 2-8 carbon atoms, one of which carbon atoms may be in the form of a carbonyl group, Y is H, alkyl, dialkylaminoethyl, aryl, aralkyl or aryl and aralkyl substituted with one or more R, and R is H, lower alkyl, lower alkoxy, halogen, CF.sub.3, NO.sub.2, OH, CN, COOR.sub.1, ##STR2## NHCOR.sub.1, NR.sub.1 R.sub.2 or ##STR3## where R.sub.1 and R.sub.2 are each selected from the group consisting of H and lower alkyl; R, R.sub.1 and R.sub.2 being the same or different, T is selected from the group consisting of O, NH, S and CH.sub.2 with the proviso that only one T is O, Z is 0 or 1 and n is 0-5; and pharmaceutically acceptable salts thereof, to in vivo and in vitro platelet systems.
    • 通过添加选自下列化合物的成员来抑制血小板聚集或血栓形成的方法:其中X是具有2-8个碳原子的烷基或链烯基链,其中一个碳原子 可以是羰基的形式,Y是H,烷基,二烷基氨基乙基,芳基,芳烷基或芳基,被一个或多个R取代的芳烷基,R是H,低级烷基,低级烷氧基,卤素,CF 3,NO 2,OH ,CN,COOR1,NHCOR1,NR1R2或,其中R1和R2各自选自H和低级烷基; R,R 1和R 2相同或不同,T选自O,NH,S和CH 2,条件是仅一个T为O,Z为0或1,n为0-5; 和其药学上可接受的盐,用于体内和体外血小板系统。